XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Statements of Financial Condition - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Assets    
Cash and cash equivalents ($3.9 million restricted from use at both March 31, 2018 and December 31, 2017) $ 208,140 $ 267,646
Advisory fees receivable, net of allowance for doubtful accounts of $0.0 million and $0.3 million at March 31, 2018 and December 31, 2017, respectively 102,580 64,244
Other receivables 10,770 3,964
Property and equipment, net of accumulated depreciation of $63.0 million and $62.1 million at March 31, 2018 and December 31, 2017, respectively 8,627 8,602
Goodwill 215,541 217,737
Deferred tax asset, net 38,306 42,345
Other assets 15,299 6,279
Total assets 599,263 610,817
Liabilities and Equity    
Compensation payable 27,872 26,022
Accounts payable and accrued expenses 28,817 15,443
Current income taxes payable 11,537 5,311
Secured term loan payable 335,250 339,048
Contingent obligation due selling unitholders of Cogent 14,673 13,763
Deferred tax liability 3,109 2,928
Total liabilities 421,258 402,515
Common stock, par value $0.01 per share; 100,000,000 shares authorized, 44,671,945 and 43,750,170 shares issued as of March 31, 2018 and December 31, 2017, respectively; 26,248,132 and 27,084,520 shares outstanding as of March 31, 2018 and December 31, 2017, respectively 447 438
Restricted stock units 54,871 80,512
Additional paid-in capital 834,692 800,806
Exchangeable shares of subsidiary; 257,156 shares issued as of March 31, 2018 and December 31, 2017; 32,804 shares outstanding as of March 31, 2018 and December 31, 2017 1,958 1,958
Retained earnings 34,631 37,595
Accumulated other comprehensive income (loss) (23,056) (22,222)
Treasury stock, at cost, par value $0.01 per share; 18,423,813 and 16,665,650 shares as of March 31, 2018 and December 31, 2017, respectively (725,538) (690,785)
Stockholders’ equity 178,005 208,302
Total liabilities and equity $ 599,263 $ 610,817